Major study launches to map the future for kids with rare bleeding disorder
NCT ID NCT06107582
Summary
This study aims to learn more about a rare childhood bleeding disorder called immune thrombocytopenia (ITP). Researchers will follow 500 children in China diagnosed with ITP to observe their symptoms, treatments, and long-term health. The goal is to identify patterns that can help predict which patients are likely to do well and which might need more intensive care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY IMMUNE THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chinese Academy of Medical Science and Blood Disease Hospital
RECRUITINGTianjin, 300020, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.